Lozenges with xylitol, arginine, zinc, and inulin for oral health

Overview

This solution offers a novel oral health lozenge designed to improve gum health by delivering active ingredients such as Xylitol, Arginine, Zinc, and Inulin directly to the oral cavity over an extended period. The lozenge format is particularly effective because it dissolves slowly, maximizing mucosal exposure time and enabling sustained delivery to the saliva, teeth, and gingival tissues. This approach supports the growth of beneficial oral microbes while reducing bad breath, supporting saliva flow in cases of dry mouth, and aiding in enamel remineralization.

Technical specifications

Key features:

• Contains a blend of Xylitol, Arginine, Zinc, and Inulin.
• Slow dissolution rate ensures 5–12 minutes of contact with oral tissues.
• Enhances saliva stimulation and increases user compliance.
• Supports a healthier oral microbiome through prebiotic intervention.
• Potentially reduces tooth sensitivity and plaque formation while supporting pH balance.
• Inulin acts as a prebiotic carrier, promoting beneficial oral microbes.

Technology readiness level

This technology is currently at Technology Readiness Level 2, indicating that the concept has been formulated and initial experimentation is underway. Future validation plans include optimizing the formulation, conducting stability studies, completing safety and toxicology reviews, and defining regulatory pathways and claims strategies.